Can funding and training boost HIV testing in syringe programs?

NCT ID NCT06730555

Recruiting now Knowledge-focused Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving syringe service programs funding and training helps them offer routine HIV and hepatitis C testing to people who inject drugs. About 40 programs will either get this support or just receive a link to CDC resources. The goal is to see if more people get tested and linked to care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: practice facilitation and funding
What this could lead to: If successful, this could show a practical way to increase HIV and hepatitis C testing and care for people who inject drugs.
What could go wrong: This is a small, early-stage study with only 40 sites, so results may not apply broadly. It tests organizational change, not a direct medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS

Contacts and locations

Locations

University of Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.